Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 26, 2020 Category: Allergy & Immunology Authors: Melissa Bersanelli Source Type: research

Efficacy and safety of octanorm (cutaquig ®) in adults with primary immunodeficiencies with predominant antibody deficiency: a prospective, open-label study
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 26, 2020 Category: Allergy & Immunology Authors: Elena Latysheva Yulia Rodina Liudmila Sizyakina Areg Totolian Irina Tuzankina Source Type: research

Ex vivo-generated dendritic cell-based vaccines in melanoma: the role of nanoparticulate delivery systems
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 26, 2020 Category: Allergy & Immunology Authors: Mona Yazdani Mahmoud Reza Jaafari Javad Verdi Behrang Alani Mahdi Noureddini Ali Badiee Source Type: research

The characteristic of tumor immune microenvironment in pulmonary carcinosarcoma
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 26, 2020 Category: Allergy & Immunology Authors: Yanhong Cen Zhao Huang Jiangbo Ren Junhong Zhang Yan Gong Conghua Xie Source Type: research

Exploiting antibody biology for the treatment of cancer
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 25, 2020 Category: Allergy & Immunology Authors: Vidhi Khanna Jayanth Panyam Thomas S Griffith Source Type: research

Updates and new perspectives in nonmelanoma skin cancer therapy: highlights from ‘Immunotherapy Bridge’
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 25, 2020 Category: Allergy & Immunology Authors: Paolo Antonio Ascierto Claus Garbe Source Type: research

Immunotherapy for esophageal cancer: a 2019 update
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 25, 2020 Category: Allergy & Immunology Authors: Dimitrios Schizas Nikolaos Charalampakis Christo Kole Konstantinos S Mylonas Ioannis Katsaros Meina Zhao Jaffer A Ajani Amanda Psyrri Michalis V Karamouzis Theodore Liakakos Source Type: research

Economic burden of patients with advanced non-small-cell lung cancer receiving nivolumab versus chemotherapy in China
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 19, 2020 Category: Allergy & Immunology Authors: Qingqing Chai Yunjie Shen Jiangyang Du Jun Zhu Bin Wu Source Type: research

Treatment beyond progression with immune checkpoint inhibitors in non-small-cell lung cancer
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 19, 2020 Category: Allergy & Immunology Authors: Daniel Reinhorn Oded Jacobi Oded Icht Elizabeth Dudnik Ofer Rotem Alona Zer Daniel A Goldstein Source Type: research

The challenge of checkpoint inhibitors in prostate cancer: drugs for the many but useful to a few
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 16, 2020 Category: Allergy & Immunology Authors: Susan F  Slovin Source Type: research

Successful treatment of metastatic colorectal cancer with synchronous BRAF V600E mutation and dMMR with BGB-A317
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 16, 2020 Category: Allergy & Immunology Authors: Yi Cheng Xue-Feng Fang Han-Guang Hu Jiang Wang Li-Feng Sun Ying Yuan Source Type: research

Multimodal approaches to improve immunotherapy in breast cancer
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 11, 2020 Category: Allergy & Immunology Authors: Amrita Basu Krithika Kodumudi Source Type: research

Durable response to combination radiotherapy and immunotherapy in EP-resistant lung large-cell neuroendocrine carcinoma with B2M and STK11 mutations: a case report
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - March 11, 2020 Category: Allergy & Immunology Authors: Yi Qin Min Yu Lin Zhou Lili Jiang Meijuan Huang Source Type: research

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study
Immunotherapy,Volume 12, Issue 2, Page 151-159, February 2020. (Source: Immunotherapy)
Source: Immunotherapy - February 24, 2020 Category: Allergy & Immunology Authors: Melissa Bersanelli Sebastiano Buti Giuseppe Luigi Banna Ugo De Giorgi Alessio Cortellini Sara Elena Rebuzzi Marcello Tiseo Giuseppe Fornarini Francesca Mazzoni Stefano Panni Michele De Tursi Pietro Di Marino Sabrina Rossetti Ernesto Rossi Silverio Tomao E Source Type: research

Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - February 20, 2020 Category: Allergy & Immunology Authors: John V Boyle Kent K Lam Joseph K Han Source Type: research

Use of recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin in elderly patients
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - February 18, 2020 Category: Allergy & Immunology Authors: Pieter van Paassen David Pittrow Clemens Scheidegger Jens Klotsche Pauline  M Ellerbroek Source Type: research

Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - February 18, 2020 Category: Allergy & Immunology Authors: Cecilia Bozzetti Anna Squadrilli Rita Nizzoli Costanza Lagrasta Donatello Gasparro Maria Majori Massimo De Filippo Gabriella Becchi Cinzia Azzoni Nicoletta Campanini Giuseppe Pedrazzi Andrea Zavani Enrico Maria Silini Marcello Tiseo Letizia Gnetti Source Type: research

Aggravation of depigmentation for a non-small-cell lung cancer patient with pre-existing vitiligo using anti-programmed cell death-1 therapy: case report
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - February 17, 2020 Category: Allergy & Immunology Authors: Yinghui Xu Yangyang Cai Jianjiao Zu Xu Wang Yizhuo Wang Chao Sun Ye Guo Guoguang Shao Zhiguang Yang Shi Qiu Kewei Ma Source Type: research

Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitors
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - February 17, 2020 Category: Allergy & Immunology Authors: Shipra Gandhi Manu Pandey Nischala Ammannagari Chong Wang Mark J Bucsek Lamya Hamad Elizabeth Repasky Marc S Ernstoff Source Type: research

Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - February 12, 2020 Category: Allergy & Immunology Authors: Melissa Bersanelli Stefania Scala Paola Affanni Licia Veronesi Maria Eugenia Colucci Giuseppe Luigi Banna Alessio Cortellini Francesco Liotta Source Type: research

Clinical and economic outcomes of treatment sequences for intermediate- to poor-risk advanced renal cell carcinoma
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 29, 2020 Category: Allergy & Immunology Authors: Apoorva Ambavane Shuo Yang Michael B Atkins Sumati Rao Anshul Shah Meredith M Regan David F McDermott M Dror Michaelson Source Type: research

Radiation recall dermatitis after treatment of stage IV breast cancer with nivolumab: a case report
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 29, 2020 Category: Allergy & Immunology Authors: Cole Billena Shilpa Padia Bridget O ’Brien Jeanna Knoble Abhay Gokhale Malolan Rajagopalan Source Type: research

The safety of carbamylated monomeric allergoids for sublingual immunotherapy. Data from a pharmacovigilance study
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 23, 2020 Category: Allergy & Immunology Authors: Enrico Compalati Cristoforo Incorvaia Sara Urbano Paola Strada Franco Frati Source Type: research

Introducing Volume 12 of Immunotherapy
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 9, 2020 Category: Allergy & Immunology Authors: Daniel Barrett Source Type: research

CD3D is associated with immune checkpoints and predicts favorable clinical outcome in colon cancer
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 9, 2020 Category: Allergy & Immunology Authors: Yi Yang Yiwen Zang Chuang Zheng Zhenyang Li Xiaodong Gu Minwei Zhou Zihao Wang Jianbin Xiang Zongyou Chen Yiming Zhou Source Type: research

5 years of clinical DC-CIK/NK cells immunotherapy for acute myeloid leukemia  – a summary
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 9, 2020 Category: Allergy & Immunology Authors: Xian Zhang Junfang Yang Gailing Zhang Lisong Song Yunchao Su Yanze Shi Min Zhang Jiujiang He Dan Song Fanyong Lv Ping Wu Hui Wang Tong Wang Yang Zhang Hongxing Liu Peihua Lu Source Type: research

M2 macrophage immunotherapy abolishes glucose intolerance by increasing IL-10 expression and AKT activation
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 9, 2020 Category: Allergy & Immunology Authors: Diana Vega-Galaviz Georgina Del Vecchyo-Tenorio Ra úl Alcántara-Suárez Lucia A M éndez-García Ana L S ánchez-Del Real Rafael Villalobos-Molina Jos é M Fragoso Sonia Le ón-Cabrera Pedro Ostoa-Saloma Ruy P érez-Tamayo Galileo Escobedo Source Type: research

Real-life effect of a microcrystalline tyrosine adjuvanted mite immunotherapy in patients with allergic rhinitis
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 8, 2020 Category: Allergy & Immunology Authors: Albert Roger Alfons Malet Victoria Moreno Antonio Parra Diego Guti érrez Ram ón Lleonart Francisco Moreno Antonio Valero Bego ña Navarro Bel én Hinojosa Jos é L Justicia Source Type: research

Safety evaluation of a multiallergen immunotherapy treatment in polyallergic patients. APOLO observational study
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 6, 2020 Category: Allergy & Immunology Authors: Pilar Alba Victoria Moreno Jos é Arias-Irigoyen M ónica Antón Antonio Parra Mar ía Cruz Gómez-Fernández Bego ña Madariaga Alberto Mart ínez Leire Bego ña Source Type: research

Immunonutrition in patients with colon cancer
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 6, 2020 Category: Allergy & Immunology Authors: Luis S ánchez-Guillén Antonio Arroyo Source Type: research

Implications of T cell receptor biology on the development of new T cell therapies for cancer
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - January 6, 2020 Category: Allergy & Immunology Authors: Ian R Hardy Wolfgang W Schamel Patrick A Baeuerle Daniel R Getts Robert Hofmeister Source Type: research

Year-round treatment initiation for a 6-grasses pollen allergoid in specific immunotherapy of allergic rhinoconjunctivitis and asthma
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - December 19, 2019 Category: Allergy & Immunology Authors: Vera Mahler Stefan Zielen Martin Rosewich Source Type: research

Reinforcing the primary immunotherapy modulators against acute leukemia; monoclonal antibodies in AML
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - December 17, 2019 Category: Allergy & Immunology Authors: Mehrdad Mahalleh Mahsima Shabani Elham Rayzan Nima Rezaei Source Type: research

Could PD-1/PDL1 immune checkpoints be linked to HLA signature?
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - December 9, 2019 Category: Allergy & Immunology Authors: Pierpaolo Correale Rita E Saladino Valerio Nardone Rocco Giannicola Rita Agostino Luigi Pirtoli Michele Caraglia Ciro Botta Pierosandro Tagliaferri Source Type: research

In vivo tumor suppressing and anti-angiogenic activities of a recombinant anti-CD3 ε nanobody in breast cancer mice model
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - December 9, 2019 Category: Allergy & Immunology Authors: Azadeh Sharif Khatibi Nasim Hayati Roodbari Keivan Majidzade-A Parichehreh Yaghmaei Leila Farahmand Source Type: research

Cardiac tamponade in a patient with stage IV lung adenocarcinoma treated with pembrolizumab
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - December 9, 2019 Category: Allergy & Immunology Authors: Abdul Moiz Khan Ayesha Munir Vimala Thalody Mohamed Khalid Munshi Syed Mehdi Source Type: research

In vivo tumor-suppressing and anti-angiogenic activities of a recombinant anti-CD3 ε nanobody in breast cancer mice model
Immunotherapy,Volume 11, Issue 18, Page 1555-1567, December 2019. (Source: Immunotherapy)
Source: Immunotherapy - December 9, 2019 Category: Allergy & Immunology Authors: Azadeh Sharif Khatibi Nasim Hayati Roodbari Keivan Majidzade-A Parichehreh Yaghmaei Leila Farahmand Source Type: research

Nivolumab-induced large-duct cholangiopathy treated with ursodeoxycholic acid and tocilizumab
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - December 3, 2019 Category: Allergy & Immunology Authors: Chanakyaram A Reddy Bryan J Schneider Lindsay M Brackett Andrew W Tai Source Type: research

Abscopal effect in lung cancer: three case reports and a concise review
Immunotherapy,Volume 11, Issue 17, Page 1445-1461, December 2019. (Source: Immunotherapy)
Source: Immunotherapy - December 1, 2019 Category: Allergy & Immunology Authors: Elena Garelli Achim Rittmeyer Paul Martin Putora Markus Glatzer Ralf Dressel Stefan Andreas Source Type: research

Outcomes of first-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥50%) metastatic NSCLC at US oncology practices
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - November 27, 2019 Category: Allergy & Immunology Authors: Vamsidhar Velcheti Sheenu Chandwani Xin Chen M Catherine Pietanza Bilal Piperdi Thomas Burke Source Type: research

Is immunotherapy the holy grail for pancreatic cancer?
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - November 21, 2019 Category: Allergy & Immunology Authors: Roland Andersson Carlos-Filipe Pereira Monika Bauden Daniel Ansari Source Type: research

Cost –effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in USA
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - November 18, 2019 Category: Allergy & Immunology Authors: Min Huang Gilberto de Lima Lopes Ralph P Insinga Thomas Burke Flavia Ejzykowicz Ying Zhang Josephine L Feliciano Source Type: research

The efficacy of PD-1/PD-L1 inhibitors in advanced squamous-cell lung cancer: a meta-analysis of 3112 patients
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - November 12, 2019 Category: Allergy & Immunology Authors: Rui-Lian Chen Jing-Xu Zhou Yang Cao Sui-Hui Li Yong-Hao Li Mei Jiang Dong-Yan Lu Peng Li Li-Zhu Lin Source Type: research

Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysis
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - November 5, 2019 Category: Allergy & Immunology Authors: Kevin Yan Chakrapani Balijepalli Rohini Sharma Stephane Barakat Shawn X Sun Stephanie Falcao Eric Druyts J Mark FitzGerald Source Type: research

Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - October 30, 2019 Category: Allergy & Immunology Authors: Francesco Massari Vincenzo Di Nunno Veronica Mollica Rodolfo Montironi Liang Cheng Alessia Cimadamore Ana Blanca Antonio Lopez-Beltran Source Type: research

Oral plasma kallikrein inhibitor BCX7353 for treatment of hereditary angioedema
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - October 22, 2019 Category: Allergy & Immunology Authors: Jacqueline R Hwang Gloria Hwang Ansh Johri Timothy Craig Source Type: research

Immune globulin subcutaneous, human – klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - October 17, 2019 Category: Allergy & Immunology Authors: John W Sleasman William R Lumry Iftikhar Hussain H James Wedner James B Harris Kecia L Courtney Elsa Mondou Jiang Lin Mark R Stein Source Type: research

The emerging use of immune checkpoint blockade in the adjuvant setting for solid tumors: a review
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - October 17, 2019 Category: Allergy & Immunology Authors: Elissar Moujaess Fady Gh Haddad Roland Eid Hampig Raphael Kourie Source Type: research

The effectiveness of sublingual immunotherapy for house dust mite-induced allergic rhinitis and its co-morbid conditions
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - October 14, 2019 Category: Allergy & Immunology Authors: Alson Wai-ming Chan Wing Pan Luk Ling Hiu Fung Tak Hong Lee Source Type: research

Dendritic cell-based vaccine targeting aspartate- β-hydroxylas represents a promising therapeutic strategy for HCC
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - October 14, 2019 Category: Allergy & Immunology Authors: Yujiao Zhou Chengmin Li Guo Shi Xiaolei Xu Xue Luo Yuanling Zhang Jingjie Fu Limin Chen Aizhong Zeng Source Type: research